|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:DYRK2-SEC31A (FusionGDB2 ID:HG8445TG22872) |
Fusion Gene Summary for DYRK2-SEC31A |
Fusion gene summary |
Fusion gene information | Fusion gene name: DYRK2-SEC31A | Fusion gene ID: hg8445tg22872 | Hgene | Tgene | Gene symbol | DYRK2 | SEC31A | Gene ID | 8445 | 22872 |
Gene name | dual specificity tyrosine phosphorylation regulated kinase 2 | SEC31 homolog A, COPII coat complex component | |
Synonyms | - | ABP125|ABP130|HSPC275|HSPC334|NEDSOSB|SEC31L1 | |
Cytomap | ('DYRK2')('SEC31A') 12q15 | 4q21.22 | |
Type of gene | protein-coding | protein-coding | |
Description | dual specificity tyrosine-phosphorylation-regulated kinase 2dual specificity tyrosine-(Y)-phosphorylation regulated kinase 2 | protein transport protein Sec31ASEC31 homolog A, COPII coating complex componentSEC31-like protein 1SEC31-related protein Aweb1-like proteinyeast Sec31p homolog | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | Q92630 | O94979 | |
Ensembl transtripts involved in fusion gene | ENST00000537632, ENST00000344096, ENST00000393555, | ||
Fusion gene scores | * DoF score | 6 X 6 X 3=108 | 27 X 19 X 11=5643 |
# samples | 7 | 28 | |
** MAII score | log2(7/108*10)=-0.625604485218502 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(28/5643*10)=-4.33296361729939 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: DYRK2 [Title/Abstract] AND SEC31A [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | DYRK2(68043725)-SEC31A(83750211), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. | DYRK2-SEC31A seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. DYRK2-SEC31A seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. DYRK2-SEC31A seems lost the major protein functional domain in Hgene partner, which is a kinase due to the frame-shifted ORF. DYRK2-SEC31A seems lost the major protein functional domain in Tgene partner, which is a cell metabolism gene due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | DYRK2 | GO:0006468 | protein phosphorylation | 11311121 |
Hgene | DYRK2 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 17349958 |
Hgene | DYRK2 | GO:0045725 | positive regulation of glycogen biosynthetic process | 11311121 |
Tgene | SEC31A | GO:0051592 | response to calcium ion | 17196169 |
Tgene | SEC31A | GO:0090110 | cargo loading into COPII-coated vesicle | 17499046|18843296 |
Fusion gene information * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | STAD | TCGA-CD-A4MI | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
ChimerDB4 | UCEC | TCGA-B5-A11N | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
Top |
Fusion Gene ORF analysis for DYRK2-SEC31A |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
3UTR-3CDS | ENST00000537632 | ENST00000264405 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
3UTR-3CDS | ENST00000537632 | ENST00000311785 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
3UTR-3CDS | ENST00000537632 | ENST00000326950 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
3UTR-3CDS | ENST00000537632 | ENST00000348405 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
3UTR-3CDS | ENST00000537632 | ENST00000355196 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
3UTR-3CDS | ENST00000537632 | ENST00000395310 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
3UTR-3CDS | ENST00000537632 | ENST00000432794 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
3UTR-3CDS | ENST00000537632 | ENST00000443462 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
3UTR-3CDS | ENST00000537632 | ENST00000448323 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
3UTR-3CDS | ENST00000537632 | ENST00000500777 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
3UTR-3CDS | ENST00000537632 | ENST00000505472 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
3UTR-3CDS | ENST00000537632 | ENST00000505984 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
3UTR-3CDS | ENST00000537632 | ENST00000508502 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
3UTR-3CDS | ENST00000537632 | ENST00000509142 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
3UTR-3CDS | ENST00000537632 | ENST00000513858 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
3UTR-intron | ENST00000537632 | ENST00000436790 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
3UTR-intron | ENST00000537632 | ENST00000508479 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
5CDS-intron | ENST00000344096 | ENST00000436790 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
5CDS-intron | ENST00000344096 | ENST00000508479 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
Frame-shift | ENST00000344096 | ENST00000264405 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
Frame-shift | ENST00000344096 | ENST00000311785 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
Frame-shift | ENST00000344096 | ENST00000326950 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
Frame-shift | ENST00000344096 | ENST00000348405 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
Frame-shift | ENST00000344096 | ENST00000355196 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
Frame-shift | ENST00000344096 | ENST00000395310 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
Frame-shift | ENST00000344096 | ENST00000432794 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
Frame-shift | ENST00000344096 | ENST00000443462 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
Frame-shift | ENST00000344096 | ENST00000448323 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
Frame-shift | ENST00000344096 | ENST00000500777 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
Frame-shift | ENST00000344096 | ENST00000505472 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
Frame-shift | ENST00000344096 | ENST00000505984 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
Frame-shift | ENST00000344096 | ENST00000508502 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
Frame-shift | ENST00000344096 | ENST00000509142 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
Frame-shift | ENST00000344096 | ENST00000513858 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
intron-3CDS | ENST00000393555 | ENST00000264405 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
intron-3CDS | ENST00000393555 | ENST00000311785 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
intron-3CDS | ENST00000393555 | ENST00000326950 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
intron-3CDS | ENST00000393555 | ENST00000348405 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
intron-3CDS | ENST00000393555 | ENST00000355196 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
intron-3CDS | ENST00000393555 | ENST00000395310 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
intron-3CDS | ENST00000393555 | ENST00000432794 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
intron-3CDS | ENST00000393555 | ENST00000443462 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
intron-3CDS | ENST00000393555 | ENST00000448323 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
intron-3CDS | ENST00000393555 | ENST00000500777 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
intron-3CDS | ENST00000393555 | ENST00000505472 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
intron-3CDS | ENST00000393555 | ENST00000505984 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
intron-3CDS | ENST00000393555 | ENST00000508502 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
intron-3CDS | ENST00000393555 | ENST00000509142 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
intron-3CDS | ENST00000393555 | ENST00000513858 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
intron-intron | ENST00000393555 | ENST00000436790 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
intron-intron | ENST00000393555 | ENST00000508479 | DYRK2 | chr12 | 68043725 | + | SEC31A | chr4 | 83750211 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for DYRK2-SEC31A |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Top |
Fusion Protein Features for DYRK2-SEC31A |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/:68043725/:83750211) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
DYRK2 | SEC31A |
FUNCTION: Serine/threonine-protein kinase involved in the regulation of the mitotic cell cycle, cell proliferation, apoptosis, organization of the cytoskeleton and neurite outgrowth. Functions in part via its role in ubiquitin-dependent proteasomal protein degradation. Functions downstream of ATM and phosphorylates p53/TP53 at 'Ser-46', and thereby contributes to the induction of apoptosis in response to DNA damage. Phosphorylates NFATC1, and thereby inhibits its accumulation in the nucleus and its transcription factor activity. Phosphorylates EIF2B5 at 'Ser-544', enabling its subsequent phosphorylation and inhibition by GSK3B. Likewise, phosphorylation of NFATC1, CRMP2/DPYSL2 and CRMP4/DPYSL3 promotes their subsequent phosphorylation by GSK3B. May play a general role in the priming of GSK3 substrates. Inactivates GYS1 by phosphorylation at 'Ser-641', and potentially also a second phosphorylation site, thus regulating glycogen synthesis. Mediates EDVP E3 ligase complex formation and is required for the phosphorylation and subsequent degradation of KATNA1. Phosphorylates TERT at 'Ser-457', promoting TERT ubiquitination by the EDVP complex. Phosphorylates SIAH2, and thereby increases its ubiquitin ligase activity. Promotes the proteasomal degradation of MYC and JUN, and thereby regulates progress through the mitotic cell cycle and cell proliferation. Promotes proteasomal degradation of GLI2 and GLI3, and thereby plays a role in smoothened and sonic hedgehog signaling. Plays a role in cytoskeleton organization and neurite outgrowth via its phosphorylation of DCX and DPYSL2. Phosphorylates CRMP2/DPYSL2, CRMP4/DPYSL3, DCX, EIF2B5, EIF4EBP1, GLI2, GLI3, GYS1, JUN, MDM2, MYC, NFATC1, p53/TP53, TAU/MAPT and KATNA1. Can phosphorylate histone H1, histone H3 and histone H2B (in vitro). Can phosphorylate CARHSP1 (in vitro). {ECO:0000269|PubMed:11311121, ECO:0000269|PubMed:12588975, ECO:0000269|PubMed:14593110, ECO:0000269|PubMed:15910284, ECO:0000269|PubMed:16511445, ECO:0000269|PubMed:16611631, ECO:0000269|PubMed:17349958, ECO:0000269|PubMed:18455992, ECO:0000269|PubMed:18599021, ECO:0000269|PubMed:19287380, ECO:0000269|PubMed:22307329, ECO:0000269|PubMed:22878263, ECO:0000269|PubMed:23362280, ECO:0000269|PubMed:9748265}. | FUNCTION: Component of the coat protein complex II (COPII) which promotes the formation of transport vesicles from the endoplasmic reticulum (ER) (PubMed:10788476). The coat has two main functions, the physical deformation of the endoplasmic reticulum membrane into vesicles and the selection of cargo molecules (By similarity). {ECO:0000250|UniProtKB:Q9Z2Q1, ECO:0000269|PubMed:10788476}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for DYRK2-SEC31A |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
Top |
Fusion Gene PPI Analysis for DYRK2-SEC31A |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for DYRK2-SEC31A |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for DYRK2-SEC31A |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | DYRK2 | C0238198 | Gastrointestinal Stromal Tumors | 1 | CTD_human |
Hgene | DYRK2 | C3179349 | Gastrointestinal Stromal Sarcoma | 1 | CTD_human |
Tgene | C0079744 | Diffuse Large B-Cell Lymphoma | 1 | CTD_human |